Growth Metrics

Lemaitre Vascular (LMAT) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Lemaitre Vascular (LMAT) over the last 17 years, with Q3 2025 value amounting to $0.75.

  • Lemaitre Vascular's EPS (Weighted Average and Diluted) rose 5306.12% to $0.75 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.31, marking a year-over-year increase of 2622.95%. This contributed to the annual value of $1.91 for FY2024, which is 4279.65% up from last year.
  • According to the latest figures from Q3 2025, Lemaitre Vascular's EPS (Weighted Average and Diluted) is $0.75, which was up 5306.12% from $0.6 recorded in Q2 2025.
  • In the past 5 years, Lemaitre Vascular's EPS (Weighted Average and Diluted) registered a high of $0.75 during Q3 2025, and its lowest value of $0.16 during Q2 2022.
  • In the last 5 years, Lemaitre Vascular's EPS (Weighted Average and Diluted) had a median value of $0.36 in 2023 and averaged $0.38.
  • In the last 5 years, Lemaitre Vascular's EPS (Weighted Average and Diluted) surged by 13529.41% in 2021 and then plummeted by 6000.0% in 2022.
  • Quarter analysis of 5 years shows Lemaitre Vascular's EPS (Weighted Average and Diluted) stood at $0.29 in 2021, then dropped by 14.59% to $0.25 in 2022, then skyrocketed by 53.72% to $0.38 in 2023, then increased by 24.81% to $0.47 in 2024, then skyrocketed by 59.17% to $0.75 in 2025.
  • Its last three reported values are $0.75 in Q3 2025, $0.6 for Q2 2025, and $0.48 during Q1 2025.